Augmented Reality Navigation System (SIRIO) for Neuroprotection in Vertebral Tumoral Ablation

Augmented Reality Navigation System (SIRIO) for Neuroprotection in Vertebral Tumoral Ablation

(1) This study evaluates the impact of the CT-guided SIRIO augmented reality navigation system on the procedural efficacy and clinical outcomes of neuroprotection in vertebral thermal ablation (RTA) for primary and metastatic bone tumors. (2) Methods: A retrospective non-randomized analysis of 28 ve...

Full description

Saved in:
Bibliographic Details
Main Authors: Eliodoro Faiella, Rebecca Casati, Matteo Pileri, Giuseppina Pacella, Carlo Altomare, Elva Vergantino, Amalia Bruno, Bruno Beomonte Zobel, Rosario Francesco Grasso
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Current Oncology
Subjects:
interventional oncology
neuroprotection techniques
epidural dissection
navigation system
radiation dose
bone ablation
Online Access:https://www.mdpi.com/1718-7729/31/9/376
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(1) This study evaluates the impact of the CT-guided SIRIO augmented reality navigation system on the procedural efficacy and clinical outcomes of neuroprotection in vertebral thermal ablation (RTA) for primary and metastatic bone tumors. (2) Methods: A retrospective non-randomized analysis of 28 vertebral RTA procedures was conducted, comparing 12 SIRIO-assisted and 16 non-SIRIO-assisted procedures. The primary outcomes included dose-length product (DLP) and epidural dissection time. The secondary outcomes included technical success, complication rates, and pain scores at procedural time (VAS Time 0) and three months post-procedure (VAS Time 1). The statistical analyses included t-tests, Mann–Whitney U tests, and multiple regression. (3) Results: SIRIO-assisted procedures significantly reduced DLP (307.42 mGycm vs. 460.31 mGycm, <i>p</i> = 2.23 × 10<sup>−8</sup>) and procedural epidural dissection time (13.48 min vs. 32.26 min, <i>p</i> = 2.61 × 10<sup>−12</sup>) compared to non-SIRIO-assisted procedures. Multiple regression confirmed these reductions were significant (DLP: β = −162.38, <i>p</i> < 0.001; time: β = −18.25, <i>p</i> < 0.001). Pain scores (VAS Time 1) did not differ significantly between groups, and tumor type did not significantly influence outcomes. (4) Conclusions: The SIRIO system enhances neuroprotection efficacy and safety, reducing radiation dose and procedural time during spine tumoral ablation while maintaining consistent pain management outcomes.
ISSN:1198-0052
1718-7729

Similar Items